UBS Group’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,179
| Closed | -$27K | – | 10543 |
|
|
2022
Q2 | $27K | Buy |
12,179
+4,604
| +61% | +$10.2K | ﹤0.01% | 5512 |
|
|
2022
Q1 | $14K | Buy |
+7,575
| New | +$14K | ﹤0.01% | 6966 |
|
|
2021
Q4 | – | Sell |
-5,310
| Closed | -$18K | – | 9837 |
|
|
2021
Q3 | $18K | Buy |
5,310
+5,207
| +5,055% | +$17.7K | ﹤0.01% | 6174 |
|
|
2021
Q2 | $0 | Buy |
+103
| New | – | ﹤0.01% | 8904 |
|
|
2021
Q1 | – | Sell |
-364
| Closed | -$1K | – | 8466 |
|
|
2020
Q4 | $1K | Sell |
364
-1,701
| -82% | -$4.67K | ﹤0.01% | 7268 |
|
|
2020
Q3 | $4K | Buy |
2,065
+461
| +29% | +$893 | ﹤0.01% | 6589 |
|
|
2020
Q2 | $5K | Buy |
1,604
+1,337
| +501% | +$4.17K | ﹤0.01% | 6546 |
|
|
2020
Q1 | $1K | Sell |
267
-2,716
| -91% | -$10.2K | ﹤0.01% | 6931 |
|
|
2019
Q4 | $15K | Buy |
2,983
+946
| +46% | +$4.76K | ﹤0.01% | 6000 |
|
|
2019
Q3 | $12K | Buy |
2,037
+1,537
| +307% | +$9.05K | ﹤0.01% | 6110 |
|
|
2019
Q2 | $3K | Sell |
500
-2,817
| -85% | -$16.9K | ﹤0.01% | 6684 |
|
|
2019
Q1 | $22K | Sell |
3,317
-2,534
| -43% | -$16.8K | ﹤0.01% | 5419 |
|
|
2018
Q4 | $24K | Buy |
5,851
+4,312
| +280% | +$17.7K | ﹤0.01% | 5733 |
|
|
2018
Q3 | $17K | Buy |
+1,539
| New | +$17K | ﹤0.01% | 5981 |
|